Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem in patients with complicated urinary tract infection

Japanese Journal of Chemotherapy

Volumn 53, Issue SUPPL. 1, 2005, Pages 244-259

  Kamidono, Sadao ^a   Arakawa, Soichi ^a   Hirose, Takaoki ^b   Kishi, Hiroichi ^c,j   Tsugawa, Masaya ^d,k   Matsumoto, Tetsuro ^e   Tanaka, Masatoshi ^f,l   Kawahara, Motoshi ^g   Nakashima, Mitsuyoshi ^h   Kataoka, Nobumasa ^a   Shimada, Jingoro ⁱ  

^a KOBE UNIVERSITY   (Japan)

^b Hokkaido Social Insurance Hospital   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g KAGOSHIMA UNIVERSITY   (Japan)

^h HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j YOKOSUKA KYOSAI HOSPITAL   (Japan)

^k Okayama Citizens Hospital   (Japan)

^l FUKUOKA UNIVERSITY   (Japan)

more..

Author keywords

Complication; Doripenem; Double blind study; Meropenem; Urinary tract infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; DORIPENEM; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; MEROPENEM;

ABDOMINAL DISCOMFORT; ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIURIA; BASOPHILIA; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; EOSINOPHILIA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEADACHE; HOSPITAL PATIENT; HOT FLUSH; HUMAN; INCIDENCE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PYURIA; URINARY TRACT INFECTION;

EID: 23244454191     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Japanese source 51: 179-208, 2003
2. Japanese source 51: 209-232, 2003
3. Tsuji M, Ishii Y, Yamaguchi K, et al: In vitro and in vivo antibacterial activities of S-4661, a new carbapenem. Antimicrob Agents Chemother 42: 94-99, 1998
4. Japanese source 53 (Suppl 1): 57-70, 2005
5. Japanese source 53 (Suppl 1): 80-91, 2005
6. Japanese source (Suppl 1): 92-95, 2005
7. Calandra G B, Brown K R, Grad L C, et al: Review of adverse experiences and tolerability in the first 2516 patients treated with imipenem/cilastatin. Am J Med 78: 73-78, 1985
8. Calandra G B, Lydick E, Carrigan, et al: Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin. Am J Med 84: 911-918, 1988
9. Japanese source Jpn J Clin Pharmacol 21: 281-282, 1990
10. Japanese source 53 (Suppl 1): 104-123, 2005
11. Japanese source 53 (Suppl 1): 143-156, 2005
12. Japanese source 53 (Suppl 1): 216-229, 2005
13. Japanese source Chemotherapy 34: 408-441, 1986
14. Japanese source 53 (Suppl 1): 230-243, 2005
15. Japanese source Chemotherapy 43: 63-84, 1995
16. Japanese source Chemotherapy 39: 687-689, 1991
17. Japanese source 1995
18. Japanese source p. 76-82, 2001
19. Japanese source 54: 954-969, 1992